Hormone replacement therapy decreases the risk of tinnitus in menopausal women: a nationwide study.

We examined the medical records of menopausal women aged between 45 and 79 years from Taiwan's National Health Insurance Research Database of records between 1 January 2000 and 31 December 2010 to establish matched cohorts (13,920 HRT users and 41,760 nonusers). The incidence of tinnitus in HRT users and nonusers were matched 1:3 based on propensity-score matching over this ten year period. The Cox regression hazard model was used to identify risk factors of tinnitus, and results indicate that a significantly lower percentage of HRT users (P = 0.017) developed tinnitus in comparison with nonusers (0.43%, 60/13, 920 vs. 0.59%, 246/41, 760). Using Cox regressions analysis after adjustments for age and other variables (adjusted hazard ratio: 0.505 (95% confidence interval, 0.342-0.756)), we were also able to show that HRT users appeared to have a reduced risk of developing tinnitus in comparison with nonusers. Based on our observation of the lower incidence of tinnitus among HRT users in this cohort, we speculate that HRT may have provided potential benefits on the management and prevention of tinnitus among menopausal women. PMID: 29731984 [PubMed]
Source: Oncotarget - Category: Cancer & Oncology Tags: Oncotarget Source Type: research

Related Links:

Menopause Package Intro ... TBD
Source: AARP.org News - Category: American Health Source Type: news
Conclusions: Only early menopause was associated with an increased risk of OAG in our study, in contrast to previous Western studies reporting both early menopause and late menarche as associated factors. PMID: 30026984 [PubMed]
Source: Journal of Ophthalmology - Category: Opthalmology Tags: J Ophthalmol Source Type: research
From hot flashes and weight gain to vaginal dryness and hormones, how much do you know about the realities and misconceptions of menopause?
Source: AARP.org News - Category: American Health Source Type: news
We examined the possible mechanism of action and found that Pyk2 deletion promotes the proteasome-mediated degradation of estrogen receptor α (ERα), but not estrogen receptor β (ERβ). As a consequence, E2 signaling via ERβ was enhanced in Pyk2-KO OBs. In addition, we found that Pyk2 deletion and E2 stimulation had an additive effect on ERK phosphorylation, which is known to stimulate cell differentiation and survival. Our findings suggest that in the absence of Pyk2, estrogen exerts an osteogenic effect on OBs through altered ERα and ERβ signaling. Thus, targeting Pyk2, in combination ...
Source: Molecular and Cellular Endocrinology - Category: Endocrinology Source Type: research
Conclusion: Twice-yearly treatment with denosumab was associated with increased BMD among Japanese women receiving adjuvant AI therapy, regardless of the baseline characteristics or skeletal site. PMID: 30022834 [PubMed]
Source: Clinical Genitourinary Cancer - Category: Cancer & Oncology Authors: Tags: Ther Clin Risk Manag Source Type: research
Reuters Health Information
Source: Medscape General Surgery Headlines - Category: Surgery Tags: Neurology & Neurosurgery News Source Type: news
ConclusionsRCTs which investigate the impact of omega-3 supplements on vasomotor symptoms in menopausal women are scarce. A comprehensive search in a wide range of databases found only three relevant papers. Our analysis suggests that omega-3 supplements may alleviate night sweats but have no benefit in reducing hot flushes, or improving sleep quality and quality of life during the menopausal period. We recommend high quality RCTs along with a longer follow-up period to investigate this important subject, as there was insufficient evidence to conclude that omega-3 supplements are of benefit in alleviating vasomotor symptom...
Source: European Journal of Obstetrics and Gynecology and Reproductive Biology - Category: OBGYN Source Type: research
Menopause, the permanent cessation of menses as a result of ovarian aging, occurs in a median age of 51 years in most populations. As longevity increases steadily worldwide, it is expected that women will spend nearly half of their lifetime beyond the menopausal transition [1]. Menopause is associated with unfavourable changes in adiposity measures, in the lipid profile, in blood pressure and in glucose metabolism, which increase the risk of cardiovascular disease later in life [2]. Although several medical approaches are successful in preventing or treating these conditions, a holistic approach encompassing diet and lifes...
Source: Maturitas - Category: Primary Care Authors: Source Type: research
This article is protected by copyright. All rights reserved.
Source: Clinical Otolaryngology - Category: ENT & OMF Authors: Tags: Our Experience Source Type: research
Systematic reviews and meta‐analyses represent the uppermost ladders in the hierarchy of evidence. Systematic reviews/meta‐analyses suggest preliminary or satisfactory clinical evidence for agnus castus (Vitex agnus castus) for premenstrual complaints, flaxseed (Linum usitatissimum) for hypertension, feverfew (Tanacetum partenium) for migraine prevention, ginger (Zingiber officinalis) for pregnancy‐induced nausea, ginseng (Panax ginseng) for improving fasting glucose levels as well as phytoestrogens and St John's wort (Hypericum perforatum) for the relief of some symptoms in menopause. However, firm conclusions of ef...
Source: Phytotherapy Research - Category: Biochemistry Authors: Tags: Review Source Type: research
More News: Databases & Libraries | Health Insurance | Hormone Replacement Therapy | Hormones | Insurance | Men | Menopause | Study | Taiwan Health | Tinnitus | Women